Analytical Validation of a Novel MicroRNA Panel for Risk Stratification of Cognitive Impairment

Analytical Validation of a Novel MicroRNA Panel for Risk Stratification of Cognitive Impairment

We have been developing a novel approach to identify cognitive impairment-related biomarkers by profiling brain-enriched and inflammation-associated microRNA (miRNA) in plasma specimens of cognitively unimpaired and cognitively impaired patients. Here, we present an analytical validation of the nove...

Full description

Bibliographic Details
Main Authors: Arzu Kunwar, Kenny Kwabena Ablordeppey, Alidad Mireskandari, Kira Sheinerman, Michael Kiefer, Samuil Umansky, Gyanendra Kumar
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Diagnostics
Subjects:
analytical validation
mild cognitive impairment (MCI)
Alzheimer’s disease (AD)
neurodegenerative diseases
cognitive impairment
microRNA biomarkers
Online Access:https://www.mdpi.com/2075-4418/13/13/2170

Internet

https://www.mdpi.com/2075-4418/13/13/2170

Similar Items